Characterization of PSA at death in patients with metastatic castration-resistant prostate cancer.

被引：1
|
作者：
Bikkasani, Krishna
Qin, Qian
Lin, Justin
Galsky, Matt D.
Liaw, Bobby Chi-Hung
Oh, William K.
Tsao, Che-Kai
机构：
[1] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Tisch Canc Inst, New York, NY 10029 USA
[2] CUNY, Sch Med, New York, NY 10031 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.184
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
184
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PSA Flare With Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer
    Burgio, Salvatore L.
    Conteduca, Vincenza
    Rudnas, Britt
    Carrozza, Francesco
    Campadelli, Enrico
    Bianchi, Emanuela
    Fabbri, Paolo
    Montanari, Marco
    Carretta, Elisa
    Menna, Cecilia
    De Giorgi, Ugo
    CLINICAL GENITOURINARY CANCER, 2015, 13 (01) : 39 - 43
  • [2] The association of BMI and PSA density on survival among patients with metastatic or castration-resistant prostate cancer.
    Glaser, Zachary A.
    Avulova, Svetlana
    Stocks, Blair
    Penson, David F.
    Moses, Kelvin A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [3] Early PSA progression in abiraterone/enzalutamide-treated patients with metastatic castration-resistant prostate cancer.
    Lopez-Campos, Fernando
    Gomez-Iturriaga, Alfonso
    Llacer Perez, Casilda
    Henriquez, Ivan
    Peleteiro, Paula
    Lozano, Rebeca
    Castano, Ana
    Romero-Laorden, Nuria
    Molina-Cerrillo, Javier
    Alvarez-Rodriguez, Sara
    Piquer, Teresa
    Navarro-Castellon, Joaquin
    Jose Conde-Moreno, Antonio
    Ramirez-Backhaus, Miguel
    Barrionuevo, Patricia
    Garcia, Raquel
    de los Llanos Perez-Haro, Maria
    Castro, Elena
    Olmos, David
    Lorente, David
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Oral EPI-7386 in patients with metastatic castration-resistant prostate cancer.
    Pachynski, Russell Kent
    Iannotti, Nicholas
    Laccetti, Andrew Leonard
    Carthon, Bradley Curtis
    Chi, Kim N.
    Smith, Matthew Raymond
    Vogelzang, Nicholas J.
    Tu, Wilson
    Kwan, Edmond Michael
    Wyatt, Alexander William
    Villaluna, Karen
    Younginger, Brett
    Cesano, Alessandra
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [5] Metastatic castration-resistant prostate cancer
    Henriques, Vanessa
    Wenzel, Mike
    Demes, Melanie-Christin
    Koellermann, Jens
    PATHOLOGE, 2021, 42 (04): : 431 - 438
  • [6] Enzalutamide for patients with metastatic castration-resistant prostate cancer
    Ramadan, Wijdan H.
    Kabbara, Wissam K.
    Al Masri, Hiba S. Al Basiouni
    ONCOTARGETS AND THERAPY, 2015, 8 : 871 - 876
  • [7] CRLX101 plus olaparib in patients with metastatic castration-resistant prostate cancer.
    Chen, Gang
    Karzai, Fatima
    Madan, Ravi Amrit
    Cordes, Lisa M.
    Bilusic, Marijo
    Owens, Helen
    Hankin, Amy
    Williams, Monique
    Couvillon, Anna
    Gulley, James L.
    Dahut, William L.
    Thomas, Anish
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] THE ASSOCIATION OF BMI AND DM WITH SURVIVAL AMONG PATIENTS WITH METASTATIC OR CASTRATION-RESISTANT PROSTATE CANCER.
    Glaser, Zachary A.
    Avulova, Svetlana
    Stocks, Blair
    Penson, David F.
    Moses, Kelvin A.
    JOURNAL OF UROLOGY, 2017, 197 (04) : E769 - E769
  • [9] Long-term safety of darolutamide in patients with metastatic castration-resistant prostate cancer.
    Vjaters, Egils
    Fizazi, Karim
    James, Nicholas D.
    Tammela, Teuvo
    Matsubara, Nobuaki
    Priou, Frank
    Lesimple, Thierry
    Bono, Petri
    Kataja, Vesa V.
    Garcia, Jorge A.
    Protheroe, Andrew
    Aspegren, John
    Joensuu, Heikki
    Kuss, Iris
    Thiele, Silke
    Fiala-Buskies, Sabine
    Jones, Robert Hugh
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [10] Outcome of Patients with Metastatic Castration-resistant Prostate Cancer After PSA Progression with Abiraterone Acetate
    Hung, Sheng-Chun
    Wang, Shian-Shiang
    Li, Jian-Ri
    Chen, Mei-Chih
    Yang, Cheng-Kuang
    Chen, Chuan-Shu
    Ho, Hao-Chung
    Chiu, Kun-Yuan
    Cheng, Chen-Li
    Chang, Chao-Hsiang
    Ou, Yen-Chuan
    ANTICANCER RESEARCH, 2018, 38 (09) : 5429 - 5436
12345